BioSpace News Archive

Progeria Market Report 2022-2030: Increasing Awareness and Cases of Progeria Disease is a major factor Driving Industry Revenue Growth

Forecast to 2030,’ thoroughly examines the Progeria industry to provide essential data & information for the targeted readers.

July 20, 2022
·
4 min read
Schizoaffective Market Demand 2030: Rising Sedentary Lifestyle, Prevalence of Chronic Diseases, and Rise in Knowledge Regarding Schizoaffective Disorders is a major factor Driving Industry Revenue Growth

Forecast to 2030,’ thoroughly examines the Schizoaffective industry to provide essential data & information for the targeted readers.

July 20, 2022
·
5 min read
Tinnitus Management Market Demand Analysis by 2030: Increasing Geriatric Population is a major factor Driving Industry Revenue Growth

Forecast to 2030,’ thoroughly examines the Tinnitus Management industry to provide essential data & information for the targeted readers.

July 20, 2022
·
5 min read
Drug Development

HyBryte™ Phase 3 FLASH Study for the Treatment of Cutaneous T-Cell Lymphoma Published in JAMA Dermatology

Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company), announced today that the results of its successful Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) study evaluating HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma (CTCL) has been published in the Journal of the American Medical Association (JAMA) Dermatology.

July 20, 2022
·
13 min read
CVR Medical Corp. Announces Completion of 2022 1st Quarter Financial Statement

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary Carotid Stenotic Scan device (the “CSS”).

July 20, 2022
·
3 min read
BioMidwest

Orsini Specialty Pharmacy Selected as Limited Distribution Partner for AMVUTTRA™ (vutrisiran)

Orsini Specialty Pharmacy, a leader in rare diseases and gene therapies, was chosen by Alnylam Pharmaceuticals as a specialty pharmacy partner for AMVUTTRATM.

July 20, 2022
·
3 min read
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine

ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announces that the European Commission (EC) has approved an amendment to the Advance Purchase Agreement (APA) it signed in November 20211 for Valneva’s inactivated whole-virus COVID-19 vaccine, VLA2001.

July 20, 2022
·
7 min read
BioMidwest

Neogen Ceremonially Breaks Ground on $70 Million Lansing Expansion

Neogen Corporation held a ceremonial groundbreaking in anticipation of approvals on a $70 million expansion of their Lansing, Michigan, food safety facility.

July 20, 2022
·
3 min read
Biotech Beach

Xiaozao Technology Production and Processing Facilities Receive Food Safety & Quality Management Certifications

Xiaozao Technology, a green economy biotechnology company producing nutrients from microalgae, has received food safety certifications FSSC22000 and ISO 22000:2018 and quality management systems certification ISO9001:2015 for their Guangxi China facilities.

July 20, 2022
·
2 min read
Brainomix Expands Leadership Team with Appointment of Melissa Strange as Chief Financial Officer and Jérôme Galbrun as Chief Revenue Officer

Brainomix, the AI-powered medtech solutions company, today announces that it has appointed Melissa Strange as Chief Financial Officer (CFO) and Jérôme Galbrun as Chief Revenue Officer (CRO).

July 20, 2022
·
5 min read